Explore

Trendline Trendline
Gilead Sciences to Acquire Tubulis for $5 Billion, Enhancing Cancer Treatment Capabilities

Gilead Sciences to Acquire Tubulis for $5 Billion, Enhancing Cancer Treatment Capabilities

Gilead Sciences to Acquire Tubulis for $5 Billion, Enhancing Cancer Treatment Capabilities
Trendline Trendline
Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research

Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research

Paul Spreen Appointed as Chief Commercial Officer to Drive Growth at Premier Research
Trendline Trendline
Takeda Ends Partnership with Denali, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali, Returns Dementia Drug Rights
Trendline Trendline
Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights

Takeda Ends Partnership with Denali Therapeutics, Returns Dementia Drug Rights
Trendline Trendline
Cingulate Inc. Advances ADHD Treatment Amid Regulatory Focus

Cingulate Inc. Advances ADHD Treatment Amid Regulatory Focus

Cingulate Inc. Advances ADHD Treatment Amid Regulatory Focus
Trendline Trendline
Modular Devices Appoints Steve Richter as CEO to Lead Growth Strategy

Modular Devices Appoints Steve Richter as CEO to Lead Growth Strategy

Modular Devices Appoints Steve Richter as CEO to Lead Growth Strategy
Trendline Trendline
Evommune to Explore MRGPRX2 Inhibition for Migraine Treatment

Evommune to Explore MRGPRX2 Inhibition for Migraine Treatment

Evommune to Explore MRGPRX2 Inhibition for Migraine Treatment
Trendline Trendline
Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges

Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges

Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges
Trendline Trendline
Centene Corporation Restructures Executive Leadership to Enhance Healthcare Services

Centene Corporation Restructures Executive Leadership to Enhance Healthcare Services

Centene Corporation Restructures Executive Leadership to Enhance Healthcare Services
Trendline Trendline
Allucent Expands Leadership to Enhance Drug Development for Biopharma

Allucent Expands Leadership to Enhance Drug Development for Biopharma

Allucent Expands Leadership to Enhance Drug Development for Biopharma
Trendline Trendline
Modular Devices Appoints Steve Richter as CEO to Drive Strategic Growth

Modular Devices Appoints Steve Richter as CEO to Drive Strategic Growth

Modular Devices Appoints Steve Richter as CEO to Drive Strategic Growth
Trendline Trendline
Pharmaceutical R Pipeline Experiences First Decline in Decades, Citeline Reports

Pharmaceutical R Pipeline Experiences First Decline in Decades, Citeline Reports

Pharmaceutical R Pipeline Experiences First Decline in Decades, Citeline Reports